In moments of uncertainty, bold decisions shape the future. The sixth Women in MedTech Breakfast brings together accomplished women executives to share powerful stories of taking risks, trusting their judgment, and leading with conviction when the stakes were high. Through candid conversation and lived experience, the discussion will inspire women to embrace courageous decision-making, redefine their relationship with risk, and step confidently into their leadership power. The program continues with curated small-group breakout discussions led by senior leaders from Medtronic, Baxter, Boston Scientific, the University of Minnesota, and more.
This keynote conversation with Heather Knight, Chief Commercial Officer of Solventum, explores how she’s building a modern commercial engine inside a newly independent healthcare company. The discussion touches on leadership, go-to-market strategy, and what it takes to turn innovation into real-world impact at scale.
From polymer valves to novel transcatheter approaches, the discussion will explore the science — and the business decisions — driving next-generation heart therapies. Panelists will offer an inside look at the design challenges, regulatory realities, and clinical demands shaping development in this rapidly evolving space. Expect a candid conversation about what it takes to move breakthrough concepts from the lab to lasting impact in the clinic.
Industry Panels
Where
Memorial Hall
10:30 AM - 11:20 AM
AI in MedTech: Promise, Risk, and the Path to Market
By Eric Henry Sr. Advisor, Health of Quality Compliance | Brooke & Associates, Brenna Loufek Director of AI, Regulatory & Quality | Mayo Clinic, Tealman Bjoraker Director of Regulatory Affairs | Medtronic, Mac McKeen Fellow, Regulatory Science - Retired | Adjunct Professor University of Minnesota, Mark Wehde Chair, Mayo Clinic Engineering | Mayo Clinic
This panel will bring together leaders in healthcare, medical device development, and regulatory science to examine how AI is reshaping clinical practice and product innovation. Speakers will explore the growing use of AI-enabled tools—from diagnostics and workflow optimization to personalized monitoring—and how these technologies are accelerating new models of care. Panelists will also address the risk management and regulatory considerations essential to AI-driven medical technologies, including algorithm validation, data integrity, and evolving FDA expectations.
Industry Panels
Where
University Hall
10:30 AM - 11:20 AM
From Concept to Company: Introduction to the Bakken Medical Devices Center
By Hubert Lim, PhD Director | Earl E. Bakken Medical Devices Center, Danny Sachs, MD Director, Innovation Fellows Program | Institute for Engineering in Medicine
Starting a medical device company is a lonely, long, and hard road. Idea-stage founders cannot know it all: targeting the right customer, prototyping, building a team, grant writing, patent protection, trial design, creating a fundable plan and raising funds. Attendees will learn how we help founders find community, build momentum, and move from idea to launch.
Industry Panels
Where
Thomas H. Swain Room
10:30 AM - 10:50 AM
Vail Scientific: From Hours to Minutes in Sepsis Detection - Speeding Sepsis Screening at Triage with Rapid Noninvasive Breath Analysis
By Tom Burke Chief Executive Officer and Chairman of the Board | Vail Scientific
Sepsis can become deadly within hours, but traditional testing may take too long for frontline triage decisions. Vail Scientific is working to change that. CEO Tom Burke will share how the company’s VSNO technology enables noninvasive screening in under two minutes, with potential to transform triage and early intervention. VSNO is a rapid, noninvasive breath-based screening device that measures exhaled biomarkers to help identify sepsis risk earlier. Beyond the device, this is a story of tackling a long-stagnant clinical challenge, translating sensing science into practical workflows, and building a company around an urgent unmet need. For medtech leaders, Vail highlights how focused innovation can reshape critical care pathways.
Technical Talks
Where
Heritage Gallery
11:00 AM - 11:20 AM
Peytant Solutions: From complex FDA marketing application to market advantage
By John Schorgl Cofounder, Chairman & CEO | Peytant Solutions
Turning regulatory complexity into competitive advantage, Peytant has transformed from a startup with a vision into a company defining a new category of care. CEO John Schorgl will share the Peytant journey with its AMStent®System, which combines two proven materials – a nitinol stent and a human- sourced amniotic membrane -- in a fundamentally new way. More than a product story, this is about category creation -- using early, strategic regulatory engagement to differentiate and to establish a new option for care. For medtech leaders and investors, Peytant offers a compelling blueprint for building defensible innovation in today’s environment. This session will explore Peytant’s approach to turning regulatory hurdles into opportunity. Attendees will learn how the company brought its AMStent System, designed to expand options for patients with cancers of the lung, from concept to commercialization.
Technical Talks
Where
Heritage Gallery
11:25 AM - 11:50 AM
Tecan: Lessons learned from scaling the world’s most complex builds
By Bhavin Shah Vice President, Engineering | Tecan
As medical and life sciences systems increasingly integrate optics, fluidics, electronics, robotics, and software, moving from prototype to reliable production has become one of the hardest challenges engineering teams face. Design transfer, subsystem integration, and scaling manufacturing often expose hidden complexity that can threaten yield, reliability, and launch timelines. In this session, we share practical lessons from real programs that successfully transitioned complex platforms into production. Attendees will learn how to identify hidden risks early, avoid common design transfer pitfalls, and build manufacturability into systems from the start. The session will also highlight the operational discipline required to protect quality, traceability, and yield as volumes grow.
Sponsored Sessions
Where
University Hall
11:25 AM - 11:50 AM
IQVIA MedTech: Bridging the gap - current insights in US medtech value demonstration
By Devjani Saha, PhD Director, Neurology Regulatory Affairs | IQVIA MedTech, Ann Mayer, PhD Senior Principal, US MedTech Consulting Services | IQVIA MedTech, Raj Stewart, PhD Principal, US MedTech Market Access | IQVIA MedTech
Across our national healthcare system, stakeholders ranging from clinicians to payers rely on shared, and differing, measures of value to determine which existing and emerging technologies will best serve patient needs. While medtech is experiencing a golden age of innovation, driven by breakthroughs in artificial intelligence integration; personalized medicine; and the use of wearables and implantables that treat and/or diagnose while generating novel data, a need still exists for collecting and communicating clinical, safety, and qualitative patient outcomes benefits in ways that resonate with the gatekeepers who control access to the healthcare marketplace. In this environment, it is critical to know how to position medtech products and leverage thoughtful planning and creative strategies to unlock coverage and reimbursement. Moderated by Ann Mayer, Senior Principal, IQVIA US Medtech Consulting practice, this panel will feature experts from health technology assessment, medtech regulatory, and payer perspectives discussing the present and near-future landscape for how manufacturers can optimize resonant evidence and convey value that leads to commercial success.
Sponsored Sessions
Where
Thomas H. Swain Room
12:00 PM - 12:25 PM
Rilla: Moneyball for Sales - How AI Is Changing the Game in MedTech
By Hayden Eyre Head of Business Development | Rilla
Just as Moneyball transformed baseball by replacing gut instinct with data, Rilla's AI is giving MedTech sales leaders visibility into what their reps actually say and do in the field. Learn how conversation intelligence is turning every sales visit into a coachable moment.
Sponsored Sessions
Where
University Hall
12:00 AM - 12:25 PM
Outcomes Rocket: From Portfolio to Pipeline - How Medtech Marketers Turn Buyer Insight Into Commercial Momentum
By Saul Marquez CEO | Outcomes Rocket, Caitlin Mayer Senior Director, US Marketing Acute Care & Monitoring | Medtronic
In medtech, marketing has never been harder. Buying cycles are long, clinical decisions are multi-stakeholder, and product portfolios compete for attention inside the same accounts. So how do the best medtech marketing leaders actually build commercial momentum across a portfolio, not just for a single launch?
Join Caitlin Mayer, Senior Director, US Marketing at Medtronic Acute Care & Monitoring, and Saul Marquez, CEO of Outcomes Rocket, for a candid conversation about what it takes to move from activity to impact. They will unpack the shift from feature-led to outcomes-led positioning, the role of voice-of-customer research in sharpening how a portfolio shows up in the market, and how aligning clinical, commercial, and marketing teams around a shared narrative accelerates pipeline velocity. Drawing on Outcomes Rocket's 2026 State of B2B GTM Strategy research and real work inside one of the most complex medtech portfolios, the session will explore how the right frameworks and partnerships help marketing leaders do more with the same team, prove contribution, and sustain momentum beyond the next budget cycle.
Attendees will leave with a practical lens for prioritizing across a portfolio, a model for building a defensible commercial story, and a clearer view of when internal ownership is enough and when external partnership can help change the trajectory.
HistoSonics CEO Mike Blue joins DeviceTalks for a keynote conversation on the rise of non-invasive tumor destruction and the company’s rapid march from breakthrough science to commercial reality. Blue will share how histotripsy is reshaping cancer treatment, what it takes to launch a category-creating technology, and why the next chapter for HistoSonics could redefine the role of surgery itself.
New neuro technologies are pushing beyond established indications and into entirely new markets — and the leaders building those pathways will share how it’s done. This DeviceTalks panel will explore the clinical, regulatory, and commercial strategies required to create demand for therapies that challenge traditional treatment models.
Industry Panels
Where
University Hall
2:00 PM - 2:20 PM
Beyond the Standalone Medical Device: Building a Person-Centered Diagnostic Platform
By Ping Yeh CEO and Cofounder | Person Health; Cofounder | Vocxi Health
What if the future of healthcare is no longer defined by individual devices, but by how they work together? Person Health is building toward that reality. CEO Ping Yeh will share the journey from developing a breakthrough breath-based diagnostic platform (Vocxi Health) to rethinking how diagnostics, data, and people connect. From early work in non-invasive sensing to creating “in vitro twins” and disease digital models, this story highlights how cross-disciplinary innovation can reshape entire categories in healthcare.
Technical Talks
Where
Heritage Gallery
2:30 PM - 2:50 PM
VitalPath: Great Design Isn’t Enough - 4 Reasons Catheter Programs Fail at Scale and How to Avoid Them
By Keng Thao Principal Quality Engineer | VitalPath, Anthony Smith Senior, NPI Engineer | VitalPath, Gunnar Wallinga Senior Manufacturing Engineer | VitalPath, Grant Thompson Principal R&D Engineer | VitalPath
As catheter designs grow more complex, the gap between development and manufacturing becomes increasingly difficult to navigate. Too often, programs that succeed in early development encounter delays, yield challenges, and costly rework when scaling to production.
Through real world examples, this panel will break down four key reasons catheter programs fail at scale and explore how cross-functional teams can address these challenges early through intentional process innovation, stronger NPD to NPI integration, and more proactive planning. Attendees will gain practical strategies to reduce risk, improve production readiness, and accelerate the path to commercialization.
Sponsored Sessions
Where
University Hall
2:30 PM - 2:50 PM
S3 Connected Health: Cybersecurity by Design - Navigating Regulation in Next-Gen Medical Device Development
By Bill Betten Director of Medtech Solutions | S3 Connected Health
Cybersecurity is no longer a technical afterthought — it is a core patient safety requirement and a fundamental pillar of modern medical device regulation. As devices become more connected, attackers have more opportunities to exploit vulnerabilities, disrupt care, and compromise sensitive data. A single breach can trigger regulatory investigations, recalls, and loss of market access — risks that no company can afford to ignore. This session will outline why cybersecurity must be treated as a strategic design priority from day one, not as a late-stage compliance exercise.
In this interview, legendary medtech entrepreneur Manny Villafaña reflects on a career defined by bold bets and breakthrough innovations. We explore the risks behind building multiple successful companies, the mindset required to challenge convention, and the lessons today’s leaders can draw from decades of pioneering work in cardiovascular technology.
Keynote
Where
Memorial Hall
3:30 PM - 4:00 PM
Networking Break
4:00 PM - 4:45 PM
Keynote Interview: Lisa D. Earnhardt, Executive Vice President and Group, President, Medical Devices, Abbott
By Lisa Earnhardt Executive Vice President and Group President, Medical Devices | Abbott
At DeviceTalks Minnesota, Lisa Earnhardt shares how a customer-first mindset has shaped her career and leadership of Abbott’s $19B device business. We’ll explore Abbott’s expansion into diabetes and new markets, and how innovation, access, and simplicity drive better outcomes for patients and clinicians alike.
Keynote
Where
Memorial Hall
4:45 PM - 6:00 PM
Closing Networking Reception
Join us in Memorial Hall for a closing networking reception. Thank you for being a part of DeviceTalks Minnesota!